{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:48:14Z","timestamp":1744174094422},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.pep.2009.09.016","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T09:28:19Z","timestamp":1254302899000},"page":"158-162","source":"Crossref","is-referenced-by-count":15,"title":["Production of recombinant anthrax toxin receptor (ATR\/CMG2) fused with human Fc in planta"],"prefix":"10.1016","volume":"70","author":[{"given":"V.","family":"Andrianov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Brodzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Spitsin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Bandurska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"McManus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Koprowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Golovkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pep.2009.09.016_bib1","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1016\/j.vaccine.2007.08.065","article-title":"Anthrax vaccination in a military population before the war in Iraq: side effects and informed choice","volume":"25","author":"Murphy","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.pep.2009.09.016_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0733-8627(02)00005-6","article-title":"Threats in bioterrorism I: CDC category A agent","volume":"20","author":"Darling","year":"2002","journal-title":"Emerg. Med. Clin. N. Am."},{"key":"10.1016\/j.pep.2009.09.016_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1126\/science.109563","article-title":"Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax","volume":"292","author":"Sellman","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pep.2009.09.016_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.pep.2009.09.016_bib5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nbt891","article-title":"Human antibodies from immunized donors are protective against anthrax toxin in vivo","volume":"21","author":"Wild","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pep.2009.09.016_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-8518-2-5","article-title":"Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed","volume":"2","author":"Sawada-Hirai","year":"2004","journal-title":"J. Immune Based Ther. Vaccines"},{"key":"10.1016\/j.pep.2009.09.016_bib7","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.vaccine.2005.01.013","article-title":"Human-derived, plant-produced monoclonal antibody for the treatment of anthrax","volume":"23","author":"Hull","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.pep.2009.09.016_bib8","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1016\/j.vaccine.2007.01.068","article-title":"Immunogenicity of a subunit vaccine against Bacillus anthracis","volume":"25","author":"Chichester","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.pep.2009.09.016_bib9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrmicro977","article-title":"Antitoxins: novel strategies to target agents of bioterrorism","volume":"2","author":"Rainey","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.pep.2009.09.016_bib10","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1462-5822.2006.00845.x","article-title":"Characterization of the interaction between anthrax toxin and its cellular receptors","volume":"9","author":"Liu","year":"2007","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.pep.2009.09.016_bib11","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor","volume":"100","author":"Scobie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pep.2009.09.016_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pep.2009.09.016_bib13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1086\/432731","article-title":"A soluble receptor decoy protects rats against anthrax lethal toxin challenge","volume":"192","author":"Scobie","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pep.2009.09.016_bib14","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1128\/AAC.01294-08","article-title":"Efficient neutralization of antibody-resistant forms of anthrax toxin by a soluble receptor decoy inhibitor","volume":"53","author":"Sharma","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pep.2009.09.016_bib15","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.vaccine.2004.11.001","article-title":"Vaccines and sera through plant biotechnology","volume":"7","author":"Koprowski","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.pep.2009.09.016_bib16","doi-asserted-by":"crossref","unstructured":"A.K. Sharma, M.K. Sharma, Plants as bioreactors: recent developments and emerging opportunities, Biotechnol. Adv. 2009 Jun 30 [Epub ahead of print].","DOI":"10.1016\/j.biotechadv.2009.06.004"},{"key":"10.1016\/j.pep.2009.09.016_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0952-7915(97)80135-5","article-title":"Immunoadhesins as research tools and therapeutic agents","volume":"9","author":"Ashkenazi","year":"1997","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.pep.2009.09.016_bib18","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1128\/IAI.00712-06","article-title":"Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity","volume":"74","author":"Vitale","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pep.2009.09.016_bib19","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/jnci\/djm132","article-title":"Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8","volume":"99","author":"Duan","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.pep.2009.09.016_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1467-7652.2005.00171.x","article-title":"HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production","volume":"4","author":"Obregon","year":"2006","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.pep.2009.09.016_bib21","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.vaccine.2008.12.050","article-title":"Immunological assessment of plant-derived avian flu H5\/HA1 variants","volume":"27","author":"Spitsin","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.pep.2009.09.016_bib22","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1073\/pnas.0503760102","article-title":"Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine","volume":"102","author":"Pogrebnyak","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pep.2009.09.016_bib23","doi-asserted-by":"crossref","first-page":"6864","DOI":"10.1073\/pnas.0701451104","article-title":"Smallpox subunit vaccine produced in planta confers protection in mice","volume":"104","author":"Golovkin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pep.2009.09.016_bib24","doi-asserted-by":"crossref","first-page":"8804","DOI":"10.1073\/pnas.0603043103","article-title":"Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells","volume":"103","author":"Brodzik","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pep.2009.09.016_bib25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.bbrc.2005.09.196","article-title":"Advances in Alfalfa mosaic virus-mediated expression of anthrax antigen in planta","volume":"338","author":"Brodzik","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pep.2009.09.016_bib26","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/IAI.58.6.1606-1613.1990","article-title":"Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin","volume":"58","author":"Little","year":"1990","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pep.2009.09.016_bib27","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1073\/pnas.0401506101","article-title":"Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor","volume":"101","author":"Lacy","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pep.2009.09.016_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pep.2006.04.011","article-title":"Expression and purification of functional human anthrax toxin receptor (ATR\/TEM8) binding domain from Escherichia coli","volume":"49","author":"Ding","year":"2006","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.pep.2009.09.016_bib29","first-page":"826","article-title":"Expression of ATR-Fc fusion protein in CHO cells","volume":"21","author":"Gao","year":"2005","journal-title":"Chin. J. Biotechnol."},{"key":"10.1016\/j.pep.2009.09.016_bib30","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1371\/journal.ppat.0030142","article-title":"A viral nanoparticle with dual function as an anthrax antitoxin and vaccine","volume":"3","author":"Manayani","year":"2007","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.pep.2009.09.016_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1348-0421.2008.00082.x","article-title":"Fusion protein consisting of the first immunoglobulin-like domain of porcine nectin-1 and Fc portion of human IgG1 provides a marked resistance against pseudorabies virus infection to transgenic mice","volume":"53","author":"Tomioka","year":"2009","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.pep.2009.09.016_bib32","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/1535-7163.MCT-07-2151","article-title":"Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenografts","volume":"7","author":"Sarup","year":"2008","journal-title":"Mol. Cancer Ther."}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592809002411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592809002411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T16:33:15Z","timestamp":1590165195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592809002411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1046592809002411"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2009.09.016","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}